TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05263973

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music
Description: The infants in the music group (Acem Aşiran Maqam music prepared by TÜMATA group) will be applied music for a about total of 12 minutes, starting 3 minutes before the ROP examination and continuing during the ROP examination, 3 minutes after ROP examination
Study: NCT05863065

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exposure to a Virtual Reality scenarios
Description: Exposure to a personalized, relaxing Virtual Reality scenario deployed by a Head-mounted tool (Oculus Quest 2). The administration was deployed in one session.
Study: NCT05749159

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: physiotherapy
Description: New physical therapy: a disposable cup (soft cup) to take 1/3 cup of room temperature water and place it on a table. The patient takes a sitting or standing position. The middle finger of both hands press tightly against the nose to seal the nasal cavity. At the same time, press the ear screen with both hands to close the ear canal. After that, bite the cup with teeth (hands do not touch the cup), and drink up 1-2 mouthfuls of water.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: physiotherapy
Description: New physical therapy: a disposable cup (soft cup) to take 1/3 cup of room temperature water and place it on a table. The patient takes a sitting or standing position. The middle finger of both hands press tightly against the nose to seal the nasal cavity. At the same time, press the ear screen with both hands to close the ear canal. After that, bite the cup with teeth (hands do not touch the cup), and drink up 1-2 mouthfuls of water.
Study: NCT06435052

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization & Reprocessing Therapy
Description: Eye Movement Desensitization and Reprocessing (EMDR) therapy will be administered face-to-face by a psychotherapist in a total of 12 sessions, with one session per week. The efficacy of EMDR therapy will be compared with Cognitive Behavioral Therapy in the treatment of Post-Traumatic Stress Disorder in Pakistan.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Behavioral Therapy
Description: Cognitive Behavioral Therapy will be comparatively checked with Eye Movement Desensitization \& Reprocessing Therapy for its efficacy. It will be administered by psychotherapist in 14 sessions (each session per week)
Study: NCT05633706

Intervention type: DEVICE
Intervention: fluid biopsy capsule
Description: Collection of a fluid biopsy from the small intestine via ingestible capsule

Intervention type: DEVICE
Intervention: fluid biopsy capsule
Description: Collection of a fluid biopsy from the small intestine via ingestible capsule

Intervention type: DEVICE
Intervention: fluid biopsy capsule
Description: Collection of a fluid biopsy from the small intestine via ingestible capsule
Study: NCT05687110

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo tumor biopsy
Study: NCT04730531

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Local infiltration with 0.25% bupivacaine and epinephrine
Description: The local infiltration will occur in 2 stages, separated by 30 minutes. The first dose will be injected just prior to the final tightening of set screws, decortication, and bone grafting, and will occur via multiple small volume injections 1 centimeter apart into the paraspinal musculature. The second injection will occur at an interval of 30 minutes following deep fascial closure and similarly consist of multiple small volume injections at 1 centimeter intervals into the subcutaneous tissue and skin.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo of equal volume injectable saline
Description: An equal volume of injectable saline will be used in the exact 2 stages as the treatment group. The first dose will be injected just prior to the final tightening of set screws, decortication, and bone grafting, and will occur via multiple small volume injections 1 centimeter apart into the paraspinal musculature. The second injection will occur at an interval of 30 minutes following deep fascial closure and similarly consist of multiple small volume injections at 1 centimeter intervals into the subcutaneous tissue and skin.
Study: NCT05900492

Intervention type: PROCEDURE
Intervention: cesarean section
Description: caesarean delivery, is the surgical procedure by which one or more babies are delivered through an incision in the mother's abdomen

Intervention type: PROCEDURE
Intervention: cesarean section
Description: caesarean delivery, is the surgical procedure by which one or more babies are delivered through an incision in the mother's abdomen

Intervention type: PROCEDURE
Intervention: cesarean section
Description: caesarean delivery, is the surgical procedure by which one or more babies are delivered through an incision in the mother's abdomen
Study: NCT06434467

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nelarabine injection
Description: Nelarabine is a prodrug of the nucleotide metabolism inhibitor deoxyguanosine analogue 9-β-arabinoguanine (ARA-G). Nelarabine undergoes catalytic transformation by adenosine deaminase (ADA), resulting in the removal of its methoxy group and conversion into ARA-G, Subsequently, ARA-G undergoes sequential monophosphorylation by deoxyguanosine kinase and deoxycytosine nucleoside kinase, yielding the active compound 5'-Guanosine triphosphate (GTP), ARA-GTP. This active compound accumulates within leukemic blast cells and binds to deoxyribonucleic acid (DNA), effectively inhibiting DNA synthesis and ultimately leading to cell death.
Study: NCT06410456

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise therapy
Description: Schroth exercises
Study: NCT05795153

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LOU064
Description: LOU064 (Open-Label) taken orally for 12 weeks
Study: NCT05122299

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Negative control group
Description: No intervention after extraction then delayed implant insertion at the site of extraction after three months
Study: NCT05633706

Intervention type: DEVICE
Intervention: fluid biopsy capsule
Description: Collection of a fluid biopsy from the small intestine via ingestible capsule
Study: NCT05122299

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Postive control
Description: Application of collagen only in the socket after extraction then delayed implant insertion at the site of extraction after three months.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Study group
Description: Application of acombination of CoQ10 and collagen hydrogel in the socket after extraction then delayed implant insertion at the site of extraction after three months.
Study: NCT04927403

Intervention type: OTHER
Intervention: multimodal integrative naturopathic therapy concept
Description: Use of conventional medicine, naturopathic approaches and complementary medical therapy methods

Intervention type: OTHER
Intervention: multimodal integrative naturopathic therapy concept
Description: Use of conventional medicine, naturopathic approaches and complementary medical therapy methods

Intervention type: OTHER
Intervention: multimodal integrative naturopathic therapy concept
Description: Use of conventional medicine, naturopathic approaches and complementary medical therapy methods

Intervention type: OTHER
Intervention: multimodal integrative naturopathic therapy concept
Description: Use of conventional medicine, naturopathic approaches and complementary medical therapy methods

Intervention type: OTHER
Intervention: multimodal integrative naturopathic therapy concept
Description: Use of conventional medicine, naturopathic approaches and complementary medical therapy methods
Study: NCT05446571

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letermovir
Description: Maternal daily administration of 240 milligrams of letermovir (1x240 mg-tablets) up-until delivery or TOP Placebo of Valaciclovir ; daily administration of 8 grams of valaciclovir (2 g (4 x500 mg-tablets) every 6 hours) up-until delivery or TOP

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Valacyclovir
Description: Maternal daily administration of 8 grams of valaciclovir (2 g (4 x500 mg-tablets) every 6 hours) up-until delivery or TOP Placebo of letermovir : (1x240 mg-tablets) up-until delivery or TOP
Study: NCT04814719

Intervention type: DRUG
Intervention: Pentosan Polysulphate Sodium
Description: Subcutaneous Injection (100mg/ml)

Intervention type: DRUG
Intervention: Placebo (Sodium Chloride Injection, 0.9%)
Description: Placebo to match PPS
Study: NCT06584734

Intervention type: OTHER
Group type: OTHER
Intervention: Not exercise
Description: Patients were withdrawn from the exercise they had previously been doing during their hemodiafiltration sessions.

Intervention type: OTHER
Group type: OTHER
Intervention: Exercise during hemodiafiltration session
Description: Exercise with cycle ergometers during hemodiafiltration session, intensity was measure with power meters in Watts units.
Study: NCT05687110

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Diagnostic Imaging
Description: Undergo medical imaging scans

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Novobiocin Sodium
Description: Given PO
Study: NCT06470971

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Anti-PD-L1 Monoclonal Antibody
Description: Receive anti-PD-L1 monoclonal antibody therapy

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Anti-PD1 Monoclonal Antibody
Description: Receive anti-PD1 monoclonal antibody therapy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo bone scan

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study: NCT05114213

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: SBRT
Description: online adaptive MR-guided hypofractionated stereotactic radiotherapy
Study: NCT05633706

Intervention type: DEVICE
Intervention: fluid biopsy capsule
Description: Collection of a fluid biopsy from the small intestine via ingestible capsule

Intervention type: DEVICE
Intervention: fluid biopsy capsule
Description: Collection of a fluid biopsy from the small intestine via ingestible capsule
Study: NCT04147065

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Duration of eradication regimen
Description: 14 day eradication regimen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duration of eradication regimen
Description: 14 day eradication regimen
Study: NCT06242015

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Carbohydrate-first meal
Description: Rice (150 grams) eaten first, followed by broccoli (150 grams) and chicken (100 grams)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Carbohydrate-last meal
Description: Broccoli (150 grams) and chicken (100 grams) eaten first, followed by rice (150 grams)
Study: NCT05134480

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Descemet membrane endothelial keratoplasty
Description: cornea transplant procedure to replace dysfunctional endothelial cell layer

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Descemet membrane endothelial keratoplasty
Description: cornea transplant procedure to replace dysfunctional endothelial cell layer
Study: NCT06470971

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Siltuximab
Description: Given IV
Study: NCT06453629

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Floreo VR
Description: 12 week VR program to help children with ASD to reduce the core symptoms of Autism

Intervention type: DEVICE
Group type: OTHER
Intervention: Floreo VR
Description: 12 week VR program to help children with ASD to reduce the core symptoms of Autism

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: VR Control
Description: 12 week program administered in VR

Intervention type: DEVICE
Group type: OTHER
Intervention: VR Control Crossover
Description: If opt in, this group will crossover at the end of 12 weeks to the Floreo VR program
Study: NCT04601194

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Coaching and Virtual Provider Program Practice
Description: 4 weekly goal setting/coaching sessions, coupled with Virtual Provider program training and practice
Study: NCT06367218

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: opioid based strategy
Description: Induction and maintenance of anesthesia with opioids

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: opioid based strategy
Description: Induction and maintenance of anesthesia with opioids
Study: NCT04992195

Intervention type: DIAGNOSTIC_TEST
Intervention: Laboratory tests and Montreal Cognitive Assessment
Description: Laboratory tests at baseline and 16 weeks (+/-4 weeks) after 2nd dose of vaccine and serological testing for IgG antibody. Participants who have a scheduled vaccination date shall undergo an MRI brain 16 weeks (+/-4 weeks) after the second dose of COVID-19 vaccination (either SinoVac or BioNTech). A face-to-face assessment 16 weeks (+/-4 weeks) will also be conducted after the 2nd dose of COVID-vaccine for evaluation of any clinical events, followed by a phone visit every 6 months. Cognitive assessment by MoCA will be performed at baseline, 16 weeks (+/-4 weeks) then every 12 months after the 2nd dose of COVID-19 vaccine.

Intervention type: DIAGNOSTIC_TEST
Intervention: Laboratory tests and Montreal Cognitive Assessment
Description: Laboratory tests at baseline and serological testing for IgG antibody to exclude past COVID-19 infection. The timing of the second MRI brain, laboratory tests, clinical and cognitive assessment will be matched with the timing in the vaccination group are available.
Study: NCT04527146

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: IMAGINE-PD
Description: The Interactive, Multimedia Approach to Genetic Counseling to INform and Educate in Parkinson's Disease (IMAGINE-PD) is a novel, interactive, web-based, audiovisual, self-guided, genetic counseling tool in the development phase. Essential genetic counseling themes, outlined by a senior certified clinical genetics counselor in accordance with national guidelines, are presented in a web-based format, utilizing videos, text, pictures, and audio. Participants can interact with IMAGINE-PD at their own pace, with the ability to move backward and forward, repeat sections, and have the ability to submit questions to the genetic counselor via e-mail.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: IMAGINE-PD
Description: The Interactive, Multimedia Approach to Genetic Counseling to INform and Educate in Parkinson's Disease (IMAGINE-PD) is a novel, interactive, web-based, audiovisual, self-guided, genetic counseling tool in the development phase. Essential genetic counseling themes, outlined by a senior certified clinical genetics counselor in accordance with national guidelines, are presented in a web-based format, utilizing videos, text, pictures, and audio. Participants can interact with IMAGINE-PD at their own pace, with the ability to move backward and forward, repeat sections, and have the ability to submit questions to the genetic counselor via e-mail.
Study: NCT06367218

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: opioid-free strategy
Description: Esketamine was used for induction and maintenance of anesthesia

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: opioid-free strategy
Description: Esketamine was used for induction and maintenance of anesthesia
Study: NCT04527146

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual genetic counseling
Description: The virtual visits will be conducted by a certified genetic counselor to provide all counseling in accordance with guidelines set forth by the National Society of Genetic Counselors. The counseling visit will be conducted in real-time on an established and secure audiovisual conferencing telemedicine platform (BlueJeans) within the PennChart/EPIC electronic medical record dashboard.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual genetic counseling
Description: The virtual visits will be conducted by a certified genetic counselor to provide all counseling in accordance with guidelines set forth by the National Society of Genetic Counselors. The counseling visit will be conducted in real-time on an established and secure audiovisual conferencing telemedicine platform (BlueJeans) within the PennChart/EPIC electronic medical record dashboard.
Study: NCT05192746

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: control group
Description: Exercise Therapy and hot pack This tendon exercise program is very effective if done consistently. There are five steps to the program: warm up, stretching exercise, strengthening exercise, stretching exercise, and heat.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: extracorporeal shock wave therapy
Description: Shock Master 500 device will be applied once a week for four weeks in total. Each treatment consists of 2000 shocks 3 bar pressure, 20 Hz. Each rESWT session will take about 10 minutes. rESWT application will be performed on the supraspinatus trigger point. In successive treatments, there will be using of an energy density equal to 0.28 mJ/mm2
Study: NCT04527146

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Virtual genetic counseling
Description: The virtual visits will be conducted by a certified genetic counselor to provide all counseling in accordance with guidelines set forth by the National Society of Genetic Counselors. The counseling visit will be conducted in real-time on an established and secure audiovisual conferencing telemedicine platform (BlueJeans) within the PennChart/EPIC electronic medical record dashboard.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telephone genetic counseling
Description: The telephone counseling will be conducted by a certified genetic counselor to provide all counseling in accordance with guidelines set forth by the National Society of Genetic Counselors.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telephone genetic counseling
Description: The telephone counseling will be conducted by a certified genetic counselor to provide all counseling in accordance with guidelines set forth by the National Society of Genetic Counselors.
Study: NCT05192746

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: high power pain threshold ultrasound
Description: High-power, pain-threshold, ultrasound therapy application (in W/cm2) in continuousmodes, to elicit threshold pain, the ultrasound probe must be kept static on the tendon.~Intensity will be gradually increased to the level of maximum pain the patient could bear. It will be kept at that level for 4 to 5 seconds and then will be reduced to the half-intensitylevel for another 15 seconds. This procedure will be repeated 3 times.High-power,
Study: NCT06367218

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway; Preserved spontaneous breathing
Description: The patient used a laryngeal mask to maintain spontaneous breathing

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway; Preserved spontaneous breathing
Description: The patient used a laryngeal mask to maintain spontaneous breathing
Study: NCT04510779

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Apple Watch
Description: Apple Watch is a smartwatch developed by Apple Inc. The heart rate variability function will be used.
Study: NCT06367218

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Double lumen tracheal tube; Mechanical ventilation
Description: The patient was mechanically ventilated using a double-lumen tracheal catheter

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Double lumen tracheal tube; Mechanical ventilation
Description: The patient was mechanically ventilated using a double-lumen tracheal catheter
Study: NCT06115343

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness
Description: Conscious awareness practice was carried out in 6 sessions. Various inventories are used depending on the nature of the session. For example, in the leaf theme, participants are asked to close their eyes and put their thoughts from the past on a leaf and drop them into running water.
Study: NCT05376163

Intervention type: OTHER
Intervention: Survey Study
Description: Headache Disabilty Index (HDI) will be applied.
Study: NCT06509295

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Calcium Hypochlorite as Root Canal Irrigant
Description: Calcium Hypochlorite used as root canal irrigant during chemo-mechanical preparation

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Calcium Hypochlorite as Root Canal Irrigant
Description: Calcium Hypochlorite used as root canal irrigant during chemo-mechanical preparation
Study: NCT04795999

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Project With
Description: There are 12 lessons in Project With, typically delivered in six weekly sessions, with each session having two one-hour long lessons and a meal with facilitators in between the two lessons. Each lesson includes a discussion of selected literary works, including poetry, short stories, and excerpts from films and other videos. The curriculum is intended to be delivered to groups of 8-12 youth. In ideal program delivery, participants also share a meal with each other and with the Youth Advocate. Shared mealtimes create group cohesion and allow Youth Advocates to connect with participants on a personal level, building trust. At the end of the Project With curriculum, youth will partake in an offsite day excursion to Camp Eaton, a wooded camp outside of Los Angeles. At Camp Eaton, Youth Advocates will lead a Project With session, lunch, bonding activities and games, and an opportunity to engage in an outdoor activity.
Study: NCT06584435

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tremelimumab
Description: Tremelimumab is administered intravenously at a fixed dose of 240 mg every 3 weeks for 1 treatment cycle until tumor recurrence or intolerable toxic effects.